We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+10.81%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.12B
AUM Growth
+$387M
Cap. Flow
-$541M
Cap. Flow %
-17.36%
Top 10 Hldgs %
13.14%
Holding
469
New
24
Increased
106
Reduced
111
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Industrials 12.39%
3 Financials 11.54%
4 Healthcare 9.22%
5 Consumer Discretionary 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSU
301
DELISTED
Kansas City Southern
KSU
-4,250
Closed -$406K
DPLO
302
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-639,655
Closed -$8.61M
PVTL
303
DELISTED
Pivotal Software, Inc.
PVTL
-18,500
Closed -$302K
DCUD
304
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
-17,371
Closed -$832K
HES.PRA
305
DELISTED
Hess Corporation
HES.PRA
-45,350
Closed -$2.25M
CELG
306
DELISTED
Celgene Corp
CELG
-6,340
Closed -$406K

Similar funds

Palisade Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Palisade Capital Management held 469 positions worth $3.12B, up 14% from $2.73B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Palisade Capital Management withdrew a net $541M in Q1 2019, closing 36 positions and reducing 111 holdings. Its most notable exit was DIPLOMAT PHARMACY, INC., an estimated $8.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Palisade Capital Management opened a new position in Altair Engineering Inc worth $9.32M.

  • Palisade Capital Management's largest Q1 2019 buy was Altair Engineering Inc: 253,138 shares worth $9.32M.
  • Palisade Capital Management added most to Primo Water Corporation in Q1 2019, an estimated $7.67M increase.
  • Palisade Capital Management's biggest Q1 2019 reduction was SS&C Technologies, cutting an estimated $18.5M.
  • Palisade Capital Management fully exited DIPLOMAT PHARMACY, INC. in Q1 2019, selling an estimated $8.61M.
  • Palisade Capital Management's ten largest holdings make up 13% of its $3.12B portfolio in Q1 2019.
  • Palisade Capital Management opened 24 new positions and closed 36 in Q1 2019.
  • Palisade Capital Management's portfolio value rose 14% quarter-over-quarter to $3.12B.

Based on Palisade Capital Management's 13F filing for Q1 2019, filed 13 May 2019.